WPD-103

N/A

Report date: 2024/02/02 17:53:30
NME

Base Information

Drug NameWPD-103
Drug Alias NameWPD-103WPD 103
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent
Mechanisms of ActionInterleukin-13 receptor subunit alpha-2 modulatorsEphrin type-A receptor 2 modulators
TargetsInterleukin-13 receptor subunit alpha-2Ephrin type-A receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWPD Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesWPD Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A